Communication and fear of cancer recurrence in colorectal cancer survivors and their partners
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Communication and fear of cancer recurrence (FCR) discordance impact colorectal cancer (CRC) survivors' quality of life. Addressing these differences is key for better survivorship care.
Area Of Science
- Oncology
- Psychosocial Oncology
- Cancer Survivorship Research
Background
- Colorectal cancer (CRC) survivorship involves complex communication dynamics between patients and partners.
- Fear of cancer recurrence (FCR) is a significant concern for survivors and their partners.
- Understanding these dyadic experiences is crucial for developing effective support strategies.
Purpose Of The Study
- To investigate communication and FCR discordance in CRC survivor-partner dyads.
- To examine the association between dyadic discordance and survivors' health-related quality of life (HRQoL).
Main Methods
- A dyadic survey was administered to 307 colorectal cancer (CRC) survivor-partner dyads.
- Communication and FCR discordance were assessed, alongside survivor HRQoL using PROMIS-29+2.
- Bivariate and multivariable logistic regression analyses were employed.
Main Results
- 29% of dyads showed discordance in cancer communication, and 26% in FCR.
- Discordance in FCR was linked to worse survivor HRQoL and receipt of radiation.
- Factors like survivor sex and partner education influenced communication discordance.
Conclusions
- Dyadic discordance in communication and FCR significantly impacts CRC survivors' HRQoL.
- Addressing differing levels of fear and concerns is vital for patient-centered survivorship care.
- Targeting FCR and communication can improve the well-being of survivors and their partners.
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
Related Concept Videos
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...